A new wrinkle in wrinkle treatments
Xeomin® was released in the United States in 2012 as an alternative injectable option with similarly effective results. All three injectables work by relaxing and softening the action of muscles. These procedures are primarily performed on the face to improve and smooth facial wrinkles. BOTOX® Cosmetic, Dysport®, and Xeomin® are part of a class of “neuromodulating” medications approved by the Food and Drug Administration (FDA) for cosmetic use.
Go beyond botox
Although most people are very familiar with BOTOX® Cosmetic at our Zest of Beauty Clinic, clients are often surprised to learn that there are other neurotoxin wrinkle treatments available. Dysport® and XEOMIN® are very closely related to BOTOX, and they treat the same conditions.
While BOTOX has been FDA approved for cosmetic use since 2002, Dysport obtained approval in 2009 and XEOMIN in 2011. In the past 10 years, BOTOX has gained an enormous following that these newer products hope to share.
The most notable difference between Dysport and BOTOX is that Dysport seems to diffuse a bit more. XEOMIN is often referred to as “naked BOTOX,” as it has none of the additives found in BOTOX or Dysport. This means that patients are less likely to develop antibodies to the product. XEOMIN results are very similar to BOTOX, emerging over the course of a week and lasting an average of 3 or 4 months.
- Vertical frown lines between the brows
- Forehead furrows
- Crow’s feet
- Neck bands